Manufacture of pharmaceutical preparations
DENKRA AS
Revenue 2025
NOK 2.8m
Operating profit
NOK 2.7m
Equity
NOK 3.9m
Incorporated
2022
Share capital
NOK 30,000
Key figures · 2025
Current ratio
5.68
Equity ratio
82.4%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 99.0% | |
| Net margin (%%) | 80.3% | |
| Return on assets (%%) | 57.5% | |
| Likviditet | ||
| Current ratio | 5.68 | |
| Working capital | 3.9m | |
| Soliditet | ||
| Equity ratio (%%) | 82.4% | |
| Debt-to-equity ratio | 0.21 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.